AnalystsDaniel BusbyDaniel Busby's Stock Forecasts
AnalystsDaniel Busby
Analyst Ranking
Bottom 19%
#3174 out of 3861 analysts
Average Return
-75.2%
Win Rate
0%0 out of 2
Risk vs Reward
Poor
Good
Daniel Busby's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
No Ratings AvailableDaniel Busby doesn't have any winning ratings in our database | |||||
Daniel Busby's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Verrica Pharmaceuticals IncVRCA | 2 | Hold | $4.00 | +5.82% | Downgrades | 3 months ago |
Endo International PLCENDP | 1 | Hold | $5.00 | N/A | Maintains | a year ago |
Agile Therapeutics IncAGRX | 1 | Buy | $5.00 | N/A | Maintains | a year ago |
Pfizer IncPFE | 1 | Hold | $44.00 | N/A | Maintains | a year ago |
Mannkind CorpMNKD | 1 | Hold | $5.00 | N/A | Initiates Coverage On | a year ago |
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.